In summary, we used the here-characterized GSCs as in vitro models to study signaling pathways in GBM, showing that NF-κB and MYC/MAX are expressed in CD44+/CD133+/Nestin+-GSC-populations. The gene discussed is MAX; the disease is glioblastoma.